Related Experiment Video
Updated: Jul 20, 2026

Generation of Patient-Derived Podocytes from Skin Biopsies
Published on: May 26, 2023
Urinary podocyte mRNA excretion in children with D+HUS: a potential marker of long-term outcome
Laura De Petris1, Jilma Patrick, Erica Christen
1Department of Pediatrics, Washington University, St. Louis, Missouri, USA.
Insights
Urinary podocyte mRNA is detectable in children with diarrhea-associated hemolytic uremic syndrome (D+HUS), indicating potential podocyturia. Further research is needed to link these biomarkers to long-term kidney outcomes in D+HUS patients.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Molecular Diagnostics
Background:
- Diarrhea-associated hemolytic uremic syndrome (D+HUS) can cause acute kidney injury and podocyte damage.
- Podocyte loss is a concern in D+HUS, potentially impacting long-term renal function.
Purpose of the Study:
- To investigate the detectability of urinary podocyte protein mRNA in children with D+HUS.
- To assess if urinary podocyte mRNA levels serve as a biomarker for poor long-term outcomes in D+HUS.
Main Methods:
- Real-time PCR was used to measure synaptopodin and nephrin mRNA levels in urine samples.
- Urine was collected daily from hospitalized children with D+HUS and from healthy volunteers.
- Patients were stratified based on urinary mRNA levels compared to controls.
Main Results:
- Eighty percent of D+HUS patients (12/15) exhibited increased urinary podocyte mRNA excretion.
- High levels of synaptopodin mRNA were found in 73% and nephrin mRNA in 33% of patients.
- Follow-up data in 13 patients showed normal blood pressure, urinalysis, and serum creatinine.
Conclusions:
- Podocyte mRNA can be isolated from routine urine samples in children with D+HUS.
- The majority of D+HUS patients demonstrate podocyturia, evidenced by synaptopodin and nephrin mRNA excretion.
- Larger studies are necessary to establish the predictive value of these urinary biomarkers for renal prognosis in D+HUS.
Background:
Diarrhea-associated hemolytic uremic syndrome (D+HUS) causes acute renal failure and may lead to podocyte loss. Objective. To determine if the urinary mRNA excretion of podocyte proteins is detectable in children with D+HUS and if it is a biomarker of a poor long-term outcome.
Methods:
Patients were randomly selected from participants in the SYNSORB Pk trial. Urine samples were collected daily during the first week of hospitalization. Specimens were also obtained in healthy volunteers. Synaptopodin and nephrin mRNA levels were measured using real-time PCR.
Results:
Fifteen children, aged 4.9+/-2.8 years, were studied. Patients were categorized based on urinary mRNA levels into normal (marker:GAPDH
Conclusion:
The isolation of podocyte mRNA from routine urine samples is feasible in children with D+HUS. Most patients have podocyturia based on synaptopodin and nephrin mRNA excretion. Larger studies with extended follow-up are required to determine the relationship of these biomarkers to long-term renal prognosis in D+HUS.
More Related Videos
08:06Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions
Published on: July 2, 2020
07:36Quantitative Real-Time PCR Evaluation of microRNA Expressions in Mouse Kidney with Unilateral Ureteral Obstruction
Published on: August 27, 2020
Related Concept Videos
Nephrons
Renal Drug Excretion: Tubular Secretion